Kyosuke Shishikura
Kyosuke Shishikura is a physician-scientist at the University of Pennsylvania, known for his involvement in groundbreaking research that uncovered how the blood pressure medication hydralazine can potentially be repurposed to fight cancer by targeting a crucial enzyme involved in tumor survival.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 7.00 | 0.05% | +0% | 331,002,651 | 156,060 | $21,000,000 | 9,901$ |
| Hungary | 1 | 7.00 | 0.11% | +0% | 9,660,351 | 10,387 | $160,000 | 172$ |
| Totals | 2 | 340,663,002 | 166,447 | $21,160,000 | 10,073$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Hungary:
Kyosuke Shishikura, a researcher at the University of Pennsylvania, explained how hydralazine works as one of the oldest vasodilators used against preeclampsia.
7
United States:
Kyosuke Shishikura, a physician-scientist at the University of Pennsylvania who was involved in the study, said in a press release from the university.
7